Regonix 40 Mg (Regorafenib) – 28 Tablets

Regonix 40 Mg (Regorafenib) is an advanced oral therapy used to treat various forms of cancer, including metastatic colorectal cancer (CRC), gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (HCC). Containing Regorafenib, Regonix 40 mg is a multi-kinase inhibitor that targets multiple protein kinases involved in tumor growth, angiogenesis, and metastatic progression.

Regonix is indicated for the treatment of:

• Metastatic Colorectal Cancer (CRC): Regonix 40 mg is used in adult patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type, an anti-EGFR therapy.
• Gastrointestinal Stromal Tumors (GIST): Regonix 40 mg is indicated for the treatment of patients with locally advanced, unresectable, or metastatic GIST who have progressed on or are intolerant to previous treatments with imatinib and sunitinib.
• Hepatocellular Carcinoma (HCC): Regonix is also used in patients with hepatocellular carcinoma who have been previously treated with sorafenib.

Clinical studies have demonstrated that Regorafenib significantly improves progression-free survival in patients with these advanced cancers, making it a valuable option in the management of difficult-to-treat malignancies.

Product Feature:

You will have the ability to order easily and pay the best price if you use Unit Pharmacy Website for buying Regonix 40 Mg (Regorafenib) medicine.